There are several factors that increase the complexity of vaccine safety monitoring and pose challenges unique to vaccines as compared to drugs. For instance, prophylactic vaccines are required to have a higher level of safety than therapeutic medicinal products as they are given to healthy population. Download this white paper to learn about:

• The Vaccine Pharmacovigilance Paradigm
• Software Solutions for Vaccine Safety Management
• Automation Technologies for Efficient Vaccine Safety Vigilance
• ArisGlobal LifeSphere^® Safety Platform